Download the Webinar: "Feasibility & Patient Outcomes of Testing, Treating & Eradicating H. Pylori Infection"
The presentation covers:
- Common causes of Gastritis, dyspepsia and peptic ulcer disease - Testing options for H. pylori infection in Primary care, Urgent cares, Emergency Departments - Benefits of Treatment - Confirming eradication
Fill out the form below to download the presentation. Once we receive your contact information we will email you the link to the presentation.
2016 Exalenz Bioscience Ltd. All Rights Reserved
Disclaimer: In the USA, the BreathID System is intended for use in the qualitative detection of H. pylori. It has FDA 510(k)
clearance and an approved NDA for the 13C-urea tablet and citrica powder.
Other applications are limited in the U.S. by U.S. federal law to Investigational Use only. In Europe, the BreathID and BreathID Hp devices have CE approval for diagnostic monitoring of the digestive system and liver.